SCHEMBL20299233

SCHEMBL20299233

N#Cc1cc(N)ccc1C1CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.40
ALDH1A1 P00352 4/20 0.40
USP2 O75604 2/20 0.40
OPRL1 P41146 1/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 6/20 0.38
HSD17B10 Q99714 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HPGD P15428 3/20 0.36
MAOA P21397 1/20 0.36
GAA P10253 2/20 0.36
GFER P55789 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15769819 0.88 KDM4E (0.46) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL30868224 0.85 KDM4E (0.43) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL23623121 0.78 KDM4E (0.38) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL30962867 0.78 HTR1B (0.51) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL20299262 0.77 KDM4E (0.47) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL20299368 0.77 KDM4E (0.47) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL20299260 0.77 KDM4E (0.47) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL24416830 0.77 KDM4E (0.42) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL24196215 0.76 MAPK1 (0.36) OPRL1MAOAJAK2TYK2MAPK1
SCHEMBL19174845 0.76 OPRL1 (0.38) ALDH1A1OPRL1HPGDKMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed
EP-3558972-A1 TETRAZOLE CONTAINING COMPOUNDS Bayer Pharma Aktiengesellschaft (DE) 2019-10-30 EP disclosed
WO-2018114783-A1 TETRAZOLE CONTAINING COMPOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS TSLP, IL5, TRPA1 KDM4E 4547/4885ALDH1A1 485/4885USP2 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.